Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Permethrin vs Ivermectin for Scabies in Children
NCT06896929Phase 2Not yet recruiting
- Sponsor
- University of Child Health Sciences and Children's Hospital, Lahore
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of permethrin and ivermectin in scabies (3 arms), sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Primary endpoint: Cure of scabies at 4 weeks. Planned start May 2025; status: not yet recruiting.
02
Drugs
permethrinivermectin
03
Conditions
scabies
Beyond the preview
Go deeper on NCT06896929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06896929.